baber/WOPTO huggingface dataset:
Patent FI-915471-A0 (FI)
Inventor: SCHRENK WALTER J
IPC: B29C48/71
Filed: 1991-11-20
Abstract: Multilayer films are generated by dividing a first stream comprised of discrete layers of one or more materials into a plurality of branch streams (14,16,18,20), redirecting or repositioning (40) the branch streams, expanding (48) and contracting (54) the branch streams in a symmetrical fashion, and recombining (56) the branch streams to form a second stream having a greater number of discrete layers than the first stream. Alternatively, the branch streams are redirected or repositioned (64), recombined (68) to form a second stream having a greater number of discrete layers than the first stream, and the second stream expanded and contracted (66) in a symmetrical fashion. A gradient in, or other distribution of, thickness is provided by independently controlling (58,60) the flow rates of the branch streams. <IMAGE>
Patent FI-920291-A0 (FI)
Inventor: OTS MARKUS
IPC: H04B7/26
Filed: 1992-01-23
Abstract: PCT No. PCT/FI93/00022 Sec. 371 Date Sep. 15, 1994 Sec. 102(e) Date Sep. 15, 1994 PCT Filed Jan. 21, 1993 PCT Pub. No. WO93/15591 PCT Pub. Date Aug. 5, 1993A method and a system for planning a cellular radio network. The method includes creation of a model representing the cellular radio network and its radio environment on a digital map. The method further includes adding system properties affecting the traffic control process of the cellular radio network to the model representing the cellular radio network and its radio environment for route specific operational simulation of the cellular radio network. The simulation preferably utilizes subscriber mobility models and immobile and/or mobile individual subscribers generated on the digital map. The simulation events are stored separately for each street, location, network element and/or cause. The optimization of the parameters of the cellular network is performed on the basis of the stored information. Simulation of an operating cellular network on the basis of statistical data obtained from the network allows an adaptive control of the system parameters.
Patent FI-920752-A0 (FI)
Inventor: BLOMQVIST BERTHOLD
IPC: E05D15/40
Filed: 1992-02-21
Abstract: PCT No. PCT/SE90/00519 Sec. 371 Date Feb. 18, 1992 Sec. 102(e) Date Feb. 18, 1992 PCT Filed Aug. 8, 1990 PCT Pub. No. WO91/02874 PCT Pub. Date Mar. 7, 1991.A swinging arm hold (8), designed to be attached between a window case (1) and a window frame (6) and comprising a basic bar (12), attached to the case, and an upper arm (11) and a lower arm (13), projecting from the ends of the basic bar, which two arms are rotatably attached to the uppermost part of an outer bar (9), which carries the frame. About the hinge between the basic bar and the upper arm a lock (18) having a lock recess (21) is mounted, rotatable in a limited way and designed to interact with a holding element (22), which projects from the lower arm. The lock recess is limited in its outermost part by guide surfaces (29, 30) for the holding element and its innermost part has an extension, which runs with an acute angle in relation to a line between any part of the recess and the swinging center (19) of the lock, mainly designed to, during the last part of the swinging movement of the frame, give the lock an idle position, which takes up less space, and allow the frame to occupy a somewhat further outwardly swung partially open position. From the disc-shaped lock an angled actuation means (35) projects outwards towards the center of the frame and constitutes one of the limits of a security recess (31), designed to limit the swinging movements of the lock.
Patent FI-921203-A0 (FI)
Inventor: GRIEBEL PETER
IPC: A61B5/352
Filed: 1992-03-20
Abstract: The invention describes a device for the recognition and diagnosis, outside hospital, of the sleep apnoea syndrome in which the physiological parameters of heart rate, breathing and snoring sounds, degree of oxygen saturation of the blood and the posture of the patient are recorded with a mobile device and stored in encoded form. The stored data are transferred to a computer and then analysed. The mobile device comprises a recording and storage unit (2) and the following measurement sensors: three ECG electrodes (3), a laryngeal microphone (4), an oximeter finger sensor (5) and a position sensor (6). The device according to the invention permits diagnosis outside hospital of sleep apnoea, the significance of which is comparable with diagnoses based on investigations in a hospital sleep laboratory.
Patent FI-925342-A0 (FI)
Inventor: CARR ALBERT A
IPC: A61P9/08
Filed: 1992-11-25
Abstract: The present invention is directed to a new 5HT2 antagonist, (+)- alpha -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol, and its use in the treatment of a number of disease states.
Patent FI-932337-A0 (FI)
Inventor: DASGUPTA PURNENDU K
IPC: G01N30/60
Filed: 1993-05-21
Abstract: Improved capillary electrophoresis apparatus of the type that generally includes a capillary tube, the capillary tube having a sample inlet end and an outlet end, a first electrode in electrical communication with the inlet end of the capillary tube, a second electrode in electrical communication with the outlet end of the capillary tube and a high voltage power supply in electrical communication with the first and second electrodes. The improvement is to connect a miniature Ion Chromatography membrane suppressor to the outlet end of the capillary tube, to connect a conductivity detector to the membrane suppressor and to place the second electrode in the regenerant compartment of the membrane suppressor. The method embodiment of the invention for anion analysis includes the steps of: (a) separating anions of interest by capillary electrophoresis in a buffer solution; (b) exchanging cations of the buffer for regenerant cations using an ion chromatography membrane suppressor to reduce the electrical conductivity of the buffer to produce a suppressed buffer; and (c) measuring the electrical conductivity of the suppressed buffer to determine the separated anions. Similarly, the method embodiment of the invention for cation analysis includes the steps of: (a) separating cations of interest by capillary electrophoresis in a buffer solution; (b) exchanging anions of the buffer for regenerant anions using a stationary means for exchanging anions thereby reducing the electrical conductivity of the buffer to produce a suppressed buffer; and (c) measuring the electrical conductivity of the suppressed buffer to determine the separated cations.
Patent FI-941050-A0 (FI)
Inventor: METCALF BENJAMIN J
IPC: C12N15/09
Filed: 1994-03-04
Abstract: The invention pertains to a novel method and plasmid system for producing abundant quantities of CRM197 protein, diphtheria toxin or other CRM proteins related to diphtheria toxin, as well as to microorganisms transformed with the novel plasmid. A particularly preferred DNA plasmid, designated pPX 3511, that combines the gene for CRM197 from the nontoxigenic betaphage and the plasmid pNG2-22 is described. The novel plasmid system is capable of transforming strains of Corynebacterium diphtheriae into strains which are capable of expressing high levels of the CRM197 protein without the use of multiple lysogens. The invention provides in elegant means for increasing protein production without having to manipulate the expression vector, such as by increasing the promoter strength, or removing the promoter from iron regulation.
Patent FI-944687-A0 (FI)
Inventor: SHIGEMITSU TOSHIRO
IPC: A61K31/535
Filed: 1994-10-06
Abstract: A use of a compound of the formula <CHEM> wherein R is an alkyl, R<1> is a hydrogen or an amino and R<2> is a carboxyl or a tetrazole, or a salt thereof for the production of a composition for the prophylaxis and treatment of myopia. The use for the prophylaxis and treatment of myopia of the present invention not only results in relaxing action on the ciliary smooth muscle of rabbit, but also brings about superior effects of prevention and treatment of myopia of the patients on whom Mydrin-M, a conventional preparation for the prophylaxis and treatment of myopia, failed to have effects. In addition, the use does not involve a mydriatic response and is advantageous for the prophylaxis and treatment of myopia.
Patent FI-944775-A0 (FI)
Inventor: LEHTINEN JUKKA
IPC: D06C15/02
Filed: 1994-10-11
Abstract: PCT No. PCT/FI95/00559 Sec. 371 Date Jul. 15, 1997 Sec. 102(e) Date Jul. 15, 1997 PCT Filed Oct. 10, 1995 PCT Pub. No. WO96/11300 PCT Pub. Date Apr. 18, 1996An apparatus for drying and smoothing a fibre web (5) between two tight bands (1, 2) that move in parallel and turn around turning rolls (6a, 6b, 7a, 7b), the first band (1) being heated with hot steam and the second band (2) being cooled with water, and the fibre web (5) being conducted through the drying zone that the bands (1, 2) define together with at least one felt or wire (3, 4) such that the fibre web (5) is in contact with the surface of the first, heated band (1) and that the felt or wire (3, 4) is between the fibre web (5) and the second, cooled band (2). In the invention, the fibre web (5) is smoothed such that the press means located in the vicinity of the first turning rolls (6a, 7a) in the travel direction of the fibre web (5) apply to it a pressure that is essentially higher than the pressure in the other parts of the drying zone. The pressure that the fibre web is subjected to in the drying zone is sufficiently high to prevent the fibre web from shrinking in the longitudinal and transverse directions, and yet sufficiently low to prevent the fibre web from becoming essentially thinner.
Patent FI-953593-A0 (FI)
Inventor: OSSLUND TIMOTHY D
IPC: G06F19/00
Filed: 1995-07-27
Abstract: Provided herein are granulocyte colony stimulating factor ("G-CSF") analogs, compositions containing such analogs, and related compositions. In another aspect, provided herein are nucleic acids encoding the present analogs or related nucleic acids, related host cells and vectors. In yet another aspect, provided herein are computer programs and apparatuses for expressing the three dimensional structure of G-CSF and analogs thereof. In another aspect, provided herein are methods for rationally designing G-CSF analogs and related compositions. In yet another aspect, provided herein are methods for treatment using the present G-CSF analogs.
Patent FI-960611-A0 (FI)
Inventor: BAETGE E EDWARD
IPC: A61P25/00
Filed: 1996-02-09
Abstract: An encapsulated cell system for implantation in the human CNS comprises one or more biocompatible capsules, each capsule containing one or more cells, said cells producing a growth or trophic factor, the encapsulated cell system producing 1-1500 ng/day of the growth or trophic factor, particularly NGF. <IMAGE>
Patent FI-964684-A0 (FI)
Inventor: DUVENECK GERT L
IPC: G01N21/78
Filed: 1996-11-25
Abstract: PCT No. PCT/EP95/01845 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed May 17, 1995 PCT Pub. No. WO95/33197 PCT Pub. Date Dec. 7, 1995The invention relates to a process for detecting luminescence with a planar dielectric optical sensor platform consisting of a transparent substrate (a) to which a thin transparent waveguiding layer (b) is applied, which sensor platform is provided with a grating for the input-coupling of the excitation light and the refractive index of said substrate (a) is lower than the refractive index of the waveguiding layer (b), by bringing a liquid sample into contact with the layer (b), and measuring the luminescence produced by substances having luminescence properties in the sample, or by substances having luminescence properties immobilized on the layer (b), optoelectronically. The invention also relates to the use of the process in quantitative affinity sensing and to the use thereof for the quantitative determination of luminescent constituents in optically turbid solutions.
Patent FI-974060-A0 (FI)
Inventor: PARISH CHRISTOPHER RICKHARD
IPC: A61K6/898
Filed: 1997-10-27
Abstract: PCT No. PCT/AU96/00238 Sec. 371 Date Oct. 28, 1997 Sec. 102(e) Date Oct. 28, 1997 PCT Filed Apr. 24, 1996 PCT Pub. No. WO96/33726 PCT Pub. Date Oct. 31, 1996Sulfated oligosaccharides, wherein the oligosaccharide has the general formula I:R1-(Rx)n-R2(I)wherein R1 and R2 and each Rx represents a monosaccharide unit, all of which may be the same or different, adjacent monosaccharide units being linked by 1->2, 1->3, 1->4 and/or 1->6 glycosidic bonds and n is an integer of from 1 to 6, and use thereof as anti-angiogenic, anti-metastatic and/or anti-inflammatory agents.
Patent IL-58455-A0 (IL)
Title: Method of rate controlled dirctional solidication of a metal casting and the article obtained thereby
IPC: C30B21/02
Filed: 1979-10-15
Abstract: An improved method of directional solidification is provided by varying the rate of withdrawal of a casting from the hot zone of a solidification furnace according to the sense of change of the perimeter to area ratio of the casting. The rates are varied to achieve desired microstructure and resultant properties in the casting. Also, the rate of withdrawal is varied according to controlled and predetermined relationships to cause the solidification interface to move through a transition section connecting sections of differing perimeter to area ratios in a manner which produces a desired microstructure in a first, transition, and second sections.
Patent IL-71231-A0 (IL)
Title: Antibiotic l 17046 and process for preparing it
IPC: C07H17/00
Filed: 1984-03-13
Abstract: The present invention is directed to a new antibiotic substance arbitrarily denominated antibiotic L 17046. This antibiotic substance is obtained from the known antibiotic substance called teicoplanin (formerly teichomycin) by chemical treatment.The new compound possesses antimicrobial activity especially against gram-positive bacteria.
Patent IL-72769-A0 (IL)
Title: Acetabular cup assembly prosthesis
IPC: A61F2/30
Filed: 1984-08-26
Abstract: An acetabular cup assembly prosthesis (10) comprises the combination of a support shell (12) for introduction into an acetabulum (16) and a socket insert (14) in nesting engagement within the shell (12). The shell (12) has a generally hemispherical outer surface (24) and a downwardly extending concavity (20) surrounded by a peripheral rim (22). At least one anchoring post (26) secures the shell (12) to the acetabulum (16), and a central opening (30) in the bottom of the concavity (20) serves as a connection location for the socket insert (14). The insert (14) has a hemispherical concavity (32) that articulates with the rounded head of a femoral prosthesis, while the outer surface (34) of the insert (14) nests within the concavity (20) of the support shell (12). A central fastening tab (36) extends from the insert (14) into locking engagement with the opening (30) in the support shell (12), and structure (44, 46) is provided to prevent relative rotation of the shell (12) and insert (14).
Patent IL-88953-A0 (IL)
Title: Method for increasing enzyme activity of organisms
IPC: C12N1/38
Filed: 1989-01-13
Abstract: In the process disclosed, the organisms are brought into contact witn inactivated elicitor-containing microorganisms, fragments of the latter, or excretions of elicitor-containing microorganisms. Only inactivated elicitor-containing bacteria, fragments of the latter, or excretions of elicitor-containing bacteria may be used to activate enzymes and promote synthesis in non-microbial organisms. The process can be used, for example, to promote synthesis in microorganisms or plants which produce pigments, antibiotics, alkaloids or phytoalexins or to activate enzymes in microorganisms capable of transforming steroids.
Patent IL-93425-A0 (IL)
Title: Modified pseudomonas exotoxin,its production and pharmaceutical compositions containing it
IPC: C07K14/00
Filed: 1990-02-16
Abstract: We have modified PE40 toxin by removing at least two of its four cysteine amino acid residues and have formed hybrid molecules containing modified PE40 linked to a cell recognition protein that can be an antibody, a growth factor, a hormone, a lymphokine, or another polypeptide cell recognition protein for which a specific cellular receptor exists whereby the modified PE40 toxin is directed to cell types having receptors for the cell recognition protein linked to the modified PE40.
Patent FI-20002633-A0 (FI)
Inventor: KOSKINEN JUKKA
IPC: F22B37/56
Filed: 2000-11-30
Abstract: A method and apparatus for sootblowing a recovery boiler. Sootblowers of the recovery boiler are divided into sootblowing groups, and a sootblowing interval is determined for the sootblowers. A fouling index is produced for each sootblowing group of the recovery boiler, and relative frequency values are calculated.
Patent FI-20002671-A0 (FI)
Inventor: PESIOE MAURI
IPC: A01G23/083
Filed: 2000-12-05
Abstract: A tree harvesting machine compreses a tree supporting part (1) provided with a feeding device (2) for feeding a tree in its longitudinal directon, and a cross-cutting saw (5) for cutting the tree at selectedlocations, wherein said part (1) is supported by a boom assembly (6) or the like.  At temoment of action of the cross-cutting saw (5), the tree.supporting part (1) is moved downwards, preferably automatically by means of the control automatics of the tree harvesting machine, in such a way that the force caused by the weight of the tree, tending to bend the tree (R) at the cutting point (K) and thereby tending to cleave the tree, is at least partly compensated for.  The movement (F) is controleld on the basis of one or more varioables measured before themoment of cross-cutting.  The movement is implemented by releasing pressurized medium by means of a valve for a short time from an actuator (7) driven by pressurized medium and supporting the load caused by the tree, wherein at least one of the following operating values of the valve is adjusted: the aperture, the duration of the aperture, and the closing rate of the aperture.
Patent FI-20055627-A0 (FI)
Inventor: VIROLAINEN PANU
IPC: H02M/
Filed: 2005-11-25
Abstract: A frequency converter assembly comprising a direct-voltage circuit and brake chopper means, the direct-voltage circuit including a first branch (DC+) and a second branch (DC-), and the brake chopper means including a first terminal (BRK+), a second terminal (BRK-), a brake chopper switch (S1) and control means (2). The brake chopper switch (S1) is arranged in its closed position to provide a braking connection, in which the first branch (DC+) is electrically connected to the first terminal (BRK+) and the second branch (DC-) is electrically connected to the second terminal (BRK-). The assembly is provided with a first operating state where the control means (2) are arranged to control the brake chopper switch (S1) selectively to the closed position and the open position in response to the desired power supply direction of the direct-voltage circuit. The assembly is further provided with a second operating state where the control means (2) are arranged to maintain the brake chopper switch (S1) continuously in the closed position.
Patent IL-105472-A0 (IL)
Title: Suppression of proliferating response and induction of tolerance with polymorphic class ii mhc allopeptides
IPC: C07K14/74
Filed: 1993-04-20
Abstract: Described are methods for: (a) suppressing the ability of T-cells from a mammal to proliferate in response to stimulation by nonself mammalian tissue; and (b) suppressing immune response which leads to allograft rejection in a mammal receiving an allograft from a donor mammal. The methods involve orally administering to the mammal to be thus treated a composition comprising at least one of: (i) a major histocompatibility complex Class II antigen from a second nonself mammal or from tissue of a mammal syngeneic to said nonself mammal; (ii) at least one synthetic peptide corresponding to a T-cell suppressive fragment of said Class II antigen, said composition being administered in an amount effective to suppress said proliferation. The foregoing compositions are also described.
Patent IL-107564-A0 (IL)
Title: Method of controlling polypeptide production in bacteria
IPC: C12N1/38
Filed: 1993-11-10
Abstract: Nucleic acid is provided encoding a molecule having certain variations within the phosphate-binding region of native E. coli PstS. Additionally provided are bacterial cells comprising this nucleic acid under control of the native pstS gene promoter, and optionally further comprising nucleic acid encoding a polypeptide of interest under control of the alkaline phosphatase (AP) promoter. Bacterial cells containing both pstS variant nucleic acid and polypeptide nucleic acid are cultured in a medium at a concentration of inorganic phosphate that at all phases of cell growth is above the level at which the cells are starved for phosphate. Alternatively, the cells are cultured under conditions whereby the concentration of inorganic phosphate in the culture medium is controlled during the production period so that the polypeptide is produced under the control of the partially induced AP promoter.
Patent IL-109775-A0 (IL)
Title: Tetrahydropyran derivatives, their preparation and pharmaceutical compositions containing them
IPC: A61K9/00
Filed: 1994-05-25
Abstract: The invention concerns the compounds of formula I <CHEM> wherein the substituents have various significances, in free form and, where such forms exist, in salt form. They can be prepared by various processes, e.g. by irradiation; oxidation; elimination; reduction; conversion by e.g. halogenation or acylation; deprotection of protected hydroxy groups; protection of free hydroxy groups; and separation of stereoisomeric mixtures into individual isomers. They are indicated for use as pharmaceuticals, especially as antiinflammatory, and as antiproliferative and antiinflammatory agents.
Patent IL-116227-A0 (IL)
Title: Fire protecting frame construction for openings
IPC: E06B3/267
Filed: 1995-12-01
Abstract: Metal framework for windows and doors is made of aluminium profile with closed or open hollow chambers into which thermal set, hydrophilic adsorbent material is packed. The middle part of the framework is made of aluminium which has a stamped pattern (12, 13) in order to reduce the heat flow through it.
Patent IL-127911-A0 (IL)
Title: Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
IPC: C07D/
Filed: 1997-07-17
Abstract: Substituted triazolo-pyridazine derivative compounds represented bywherein the variables are disclosed herein are selective ligands for GABA-A receptors, particularly for the alpha2 and/or alpha3 subunits.
Patent IL-131126-A0 (IL)
Title: Methods and compositions for reducing the incidence of necrotizing enterocolitis
IPC: A61P1/00
Filed: 1998-02-19
Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain omega-6 and omega-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.
Patent IL-136188-A0 (IL)
Title: Erythropoietin analogs
IPC: C07K14/505
Filed: 2000-05-16
Abstract: The following are new: (1) an analogue of human erythropoietin (hEPO) comprising a sequence including \-1 additional glycosylation site; (2) an analogue of hEPO comprising a sequence with re-arrangement of \-1 glycosylation site; (3) a DNA sequence encoding the hEPOs of (1) and (2); and (4) a eukaryotic host cell transfected with the DNA of (3).